'Revolutionary' new class of cancer drugs approved A "revolutionary" new class of cancer drug that can treat a wide range of tumours has been approved for use in Europe for the first time.
Tumour-agnostic drugs do not care where the cancer is growing in the body as long as it has a specific genetic abnormality inside.
UK doctors testing the drugs said they were "a really exciting thing". BBC News
No comments:
Post a Comment